UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.365

Sortiert nach

Mechanisms of resistance to trastuzumab emtansine (T-DM1) in HER2-positive breast cancer

British journal of cancer, 2020-03, Vol.122 (5), p.603-612

2020

Link zum Volltext

Verfügbarkeit prüfen

11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial

The Lancet (British edition), 2017-03, Vol.389 (10075), p.1195-1205

2017

Link zum Volltext

Verfügbarkeit prüfen

Role of the multidisciplinary team in breast cancer management: results from a large international survey involving 39 countries

Annals of oncology, 2012-04, Vol.23 (4), p.853-859

2012

Link zum Volltext

Verfügbarkeit prüfen

Targeting the PI3K/AKT/mTOR and Raf/MEK/ERK pathways in the treatment of breast cancer

Cancer treatment reviews, 2013-12, Vol.39 (8), p.935-946

2013

Link zum Volltext

Verfügbarkeit prüfen

Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12 155 patients

British journal of cancer, 2007-05, Vol.96 (10), p.1504-1513

2007

Link zum Volltext

Verfügbarkeit prüfen

Differences in Medial and Lateral Posterior Tibial Slope: An Osteological Review of 1090 Tibiae Comparing Age, Sex, and Race

The American journal of sports medicine, 2017-01, Vol.45 (1), p.106-113

2017

Link zum Volltext

Verfügbarkeit prüfen

Recent advances in understanding the pathogenesis of Lawsonia intracellularis infections

Veterinary pathology, 2014-03, Vol.51 (2), p.465

2014

Link zum Volltext

Verfügbarkeit prüfen

Pertuzumab: new hope for patients with HER2-positive breast cancer

Annals of oncology, 2013-02, Vol.24 (2), p.273-282

2013

Link zum Volltext

Verfügbarkeit prüfen

Clinical Application of the 70-Gene Profile: The MINDACT Trial

Journal of clinical oncology, 2008-02, Vol.26 (5), p.729-735

2008

Link zum Volltext

Verfügbarkeit prüfen

Trastuzumab-Associated Cardiac Events at 8 Years of Median Follow-Up in the Herceptin Adjuvant Trial (BIG 1-01)

Journal of clinical oncology, 2014-07, Vol.32 (20), p.2159-2165

2014

Link zum Volltext

Verfügbarkeit prüfen

Changes in the Porcine Intestinal Microbiome in Response to Infection with Salmonella enterica and Lawsonia intracellularis

PloS one, 2015-10, Vol.10 (10), p.e0139106-e0139106

2015

Link zum Volltext

Verfügbarkeit prüfen

Comparative analysis of Streptococcus suis genomes identifies novel candidate virulence-associated genes in North American isolates

Veterinary research (Paris), 2022-03, Vol.53 (1), p.23-23, Article 23

2022

Link zum Volltext

Verfügbarkeit prüfen

Radiographic Signs of Femoroacetabular Impingement Are Associated With Decreased Pelvic Incidence

Arthroscopy, 2016-05, Vol.32 (5), p.806-813

2016

Link zum Volltext

Verfügbarkeit prüfen

Pelvic incidence: an anatomic investigation of 880 cadaveric specimens

European spine journal, 2016-11, Vol.25 (11), p.3589-3595

2016

Link zum Volltext

Verfügbarkeit prüfen

Trastuzumab-Associated Cardiac Adverse Effects in the Herceptin Adjuvant Trial

Journal of clinical oncology, 2007-09, Vol.25 (25), p.3859-3865

2007

Link zum Volltext

Verfügbarkeit prüfen

P1663: THE EFFECTS OF OBESITY ON BLEEDING FREQUENCY AND PARAMETERS OF FIBRINOLYSIS IN PATIENTS WITH NON-SEVERE HEMOPHILIA

HemaSphere, 2022-06, Vol.6 (Suppl), p.1544-1545

2022

Link zum Volltext

Verfügbarkeit prüfen

Understanding the molecular epidemiology and global relationships of Brachyspira hyodysenteriae from swine herds in the United States: a multi-locus sequence typing approach

PloS one, 2014-09, Vol.9 (9), p.e107176-e107176

2014

Link zum Volltext

Verfügbarkeit prüfen

Effect of Age on Breast Cancer Outcomes in Women With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Results From a Herceptin Adjuvant Trial

Journal of clinical oncology, 2013-07, Vol.31 (21), p.2692-2698

2013

Link zum Volltext

Verfügbarkeit prüfen

Immunohistochemical versus molecular (BluePrint and MammaPrint) subtyping of breast carcinoma. Outcome results from the EORTC 10041/BIG 3-04 MINDACT trial

Breast cancer research and treatment, 2018, Vol.167 (1), p.123-131

2018

Link zum Volltext

Verfügbarkeit prüfen

Longer-Term Assessment of Trastuzumab-Related Cardiac Adverse Events in the Herceptin Adjuvant (HERA) Trial

Journal of clinical oncology, 2010-07, Vol.28 (21), p.3422-3428

2010

Link zum Volltext

Verfügbarkeit prüfen

Equine proliferative enteropathy - a review of recent developments

Equine veterinary journal, 2013-07, Vol.45 (4), p.403-409

2013

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of Tumor Response, Disease Control, Progression-Free Survival, and Time to Progression As Potential Surrogate End Points in Metastatic Breast Cancer

Journal of clinical oncology, 2008-04, Vol.26 (12), p.1987-1992

2008

Link zum Volltext

Verfügbarkeit prüfen

High concordance of protein (by IHC), gene (by FISH; HER2 only), and microarray readout (by TargetPrint) of ER, PgR, and HER2: results from the EORTC 10041/BIG 03-04 MINDACT trial

Annals of oncology, 2014-04, Vol.25 (4), p.816-823

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.365

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.178)
Mit Volltextzugriff
(1.157)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

7 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(684)
Life Sciences & Biomedicine
(597)
Humans
(377)
Female
(316)
Male
(248)
Biological And Medical Sciences
(238)
Animals
(235)
Middle Aged
(176)
Medical Sciences
(159)
Adult
(156)
Oncology
(122)
Aged
(120)
Rats
(95)
Physical Sciences
(94)
Technology
(89)
Neurosciences & Neurology
(83)
Fundamental And Applied Biological Sciences. Psychology
(82)
Neurosciences
(76)
Breast Neoplasms - Drug Therapy
(74)
Obstetrics & Gynecology
(72)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Mechanisms of resistance to trastuzumab emtansine (T-DM1) in HER2-positive breast cancer

11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial

Role of the multidisciplinary team in breast cancer management: results from a large international survey involving 39 countries

Targeting the PI3K/AKT/mTOR and Raf/MEK/ERK pathways in the treatment of breast cancer

Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12 155 patients

Differences in Medial and Lateral Posterior Tibial Slope: An Osteological Review of 1090 Tibiae Comparing Age, Sex, and Race

Recent advances in understanding the pathogenesis of Lawsonia intracellularis infections

Pertuzumab: new hope for patients with HER2-positive breast cancer

Clinical Application of the 70-Gene Profile: The MINDACT Trial

Trastuzumab-Associated Cardiac Events at 8 Years of Median Follow-Up in the Herceptin Adjuvant Trial (BIG 1-01)

Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial

Changes in the Porcine Intestinal Microbiome in Response to Infection with Salmonella enterica and Lawsonia intracellularis

Comparative analysis of Streptococcus suis genomes identifies novel candidate virulence-associated genes in North American isolates

Radiographic Signs of Femoroacetabular Impingement Are Associated With Decreased Pelvic Incidence

Pelvic incidence: an anatomic investigation of 880 cadaveric specimens

Trastuzumab-Associated Cardiac Adverse Effects in the Herceptin Adjuvant Trial

P1663: THE EFFECTS OF OBESITY ON BLEEDING FREQUENCY AND PARAMETERS OF FIBRINOLYSIS IN PATIENTS WITH NON-SEVERE HEMOPHILIA

Understanding the molecular epidemiology and global relationships of Brachyspira hyodysenteriae from swine herds in the United States: a multi-locus sequence typing approach

CNS relapses in patients with HER2-positive early breast cancer who have and have not received adjuvant trastuzumab: a retrospective substudy of the HERA trial (BIG 1-01)

Effect of Age on Breast Cancer Outcomes in Women With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Results From a Herceptin Adjuvant Trial

Immunohistochemical versus molecular (BluePrint and MammaPrint) subtyping of breast carcinoma. Outcome results from the EORTC 10041/BIG 3-04 MINDACT trial

Longer-Term Assessment of Trastuzumab-Related Cardiac Adverse Events in the Herceptin Adjuvant (HERA) Trial

Equine proliferative enteropathy - a review of recent developments

Evaluation of Tumor Response, Disease Control, Progression-Free Survival, and Time to Progression As Potential Surrogate End Points in Metastatic Breast Cancer

High concordance of protein (by IHC), gene (by FISH; HER2 only), and microarray readout (by TargetPrint) of ER, PgR, and HER2: results from the EORTC 10041/BIG 03-04 MINDACT trial

Suchergebnisse filtern